|
Stephen L. Dewey, PhD, is a clinical research consultant to Catalyst and has studied vigabatrin (CPP-109) for more than 12 years in the lab and in baboon and rat animal models. Dr. Dewey is a senior chemist at Brookhaven National Laboratory and is a recognized authority in positron emission tomography (PET), which uses certain compounds to visualize and quantify biochemical processes as well as the distribution and movement of drugs in the living human and animal body. Dr. Dewey has been with Brookhaven since 1986, serving as Assistant Chemist, Associate Chemist, Chemist, Tenured Scientist and Senior Chemist. Dr. Dewey is also a research professor of psychiatry at the New York University School of Medicine and an adjunct professor of neurobiology and behavior at SUNY at Stony Brook. Dr. Dewey has been developing a novel approach to treating addiction within Brookhaven's PET program and is devoted to research within this area and sharing this research with the public. | 